Area of research
Biomedical Engineering · Toxicology
Research interest
Research focused on Tofacitinib and microRNA, with related work in Infliximab, Mendelian randomization, Meta-analysis. Notable publications include 'Safety of TNF-α inhibitors: A real-world study based on the US FDA Adverse Event Reporting System Database', 'Exploring the evolutionary mechanism of hepatitis B and gastric cancer based on Mendelian randomization combined with bioinformatics analysis', and 'Safety issues of tofacitinib in rheumatoid arthritis patients: real-world pharmacovigilance'.
Safety issues of tofacitinib in rheumatoid arthritis patients: real-world pharmacovigilance
Identification of a potential miRNA–mRNA regulatory network for ischemic stroke by using bioinformatics methods: a retrospective study based on the Gene Expression Omnibus database
The adverse reactions of bevacizumab in combination with the FOLFOX chemotherapy regimen in metastatic colorectal cancer
Safety of TNF-α inhibitors: A real-world study based on the US FDA Adverse Event Reporting System Database
Exploring the evolutionary mechanism of hepatitis B and gastric cancer based on Mendelian randomization combined with bioinformatics analysis
Efficacy and safety of acupuncture for painful diabetic neuropathy: a systematic review and meta-analysis